PORTAGE BIOTECH INC.

Analyst Reco. Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Delayed Nasdaq Other stock markets 09:44:42 2024-04-30 am EDT			5-day change	1st Jan Change
0.2401 ^USD	-7.65%		-1.03%	-86.81%

Apr. 15	Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	CI
Apr. 12	Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Downgrades Portage Biotech to Neutral From Buy	Jan. 08	MT
HC Wainwright Cuts Price Target on Portage Biotech to $9 From $21, Maintains Buy Rating	23-08-02	MT
Cantor Fitzgerald Adjusts Price Target on Portage Biotech to $11 From $16, Maintains Overweight Rating	23-08-01	MT
HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating	22-12-01	MT
Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating	22-11-30	MT
HC Wainwright Adjusts Price Target on Portage Biotech to $22 From $32, Reiterates Buy Rating	22-09-20	MT
Cantor Fitzgerald Adjusts Portage Biotech Price Target to $26 From $35, Maintains Overweight Rating	22-08-02	MT
HC Wainwright Initiates Portage Biotech at Buy with $32 Price Target	22-03-07	MT
PORTAGE BIOTECH : Oppenheimer Initiates Coverage on Portage Biotech With Outperform Rating, $30 Price Target	21-09-21	MT
PORTAGE BIOTECH : B. Riley Starts Portage Biotech at Buy with $40 PT, Notes 'Significant' Upside Potential in Solid Tumor Markets	21-09-02	MT
PORTAGE BIOTECH : Cantor Fitzgerald Starts Portage Biotech at Overweight With $35 Price Target	21-08-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer